Zum Hauptinhalt springen

Detection and differentiation of specific strains of citrus tristeza virus

Niblett, Charles
2000
Online Patent

Titel:
Detection and differentiation of specific strains of citrus tristeza virus
Autor/in / Beteiligte Person: Niblett, Charles
Link:
Veröffentlichung: 2000
Medientyp: Patent
Sonstiges:
  • Nachgewiesen in: USPTO Patent Grants
  • Sprachen: English
  • Patent Number: 6,140,046
  • Publication Date: October 31, 2000
  • Appl. No: 08/904,290
  • Application Filed: July 31, 1997
  • Assignees: University of Florida (Gainesville, FL)
  • Claim: What is claimed is
  • Claim: 1. A probe for detecting a strain of Citrus Tristeza Virus, the probe comprising an isolated nucleic acid molecule that hybridizes at 42 degrees Celsius in the presence of 6.times.SSC and 1% SDS to a complement of an oligonucleotide selected from the group consisting of: SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:9, wherein the nucleic acid molecule is selected from the group consisting of: SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:9.
  • Claim: 2. The probe of claim 1 further comprising a detectable label.
  • Claim: 3. The probe of claim 2 wherein the detectable label is biotin.
  • Claim: 4. A probe for detecting a strain of Citrus Tristeza Virus, the probe comprising an isolated nucleic acid molecule that hybridizes at 42 degrees Celsius in the presence of 6.times.SSC and 1% SDS to an oligonucleotide selected from the group consisting of: SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:9, wherein the nucleic acid molecule is selected from the group consisting of the complements of: SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:9.
  • Claim: 5. The probe of claim 4 further comprising a detectable label.
  • Claim: 6. The probe of claim 5 wherein the detectable label is biotin.
  • Claim: 7. A method for differentiating among strains of Citrus Tristeza Virus comprising the steps of
  • Claim: providing a test sample comprising at least one strain of Citrus Tristeza Virus to be identified;
  • Claim: providing at least a first oligonucleotide probe and a second oligonucleotide probe, said first oligonucleotide probe hybridizing at 42 degrees Celsius in the presence of 6.times.SSC and 1% SDS to a nucleic acid molecule selected from the group consisting of SEQ ID NOS 1-8 and the complements of SEQ ID NOS 1-8, and said second oligonucleotide probe hybridizing at 42 degrees Celsius in the presence of 6.times.SSC and 1% SDS to a nucleic acid molecule selected from the group consisting of SEQ ID NOS 1-8 and the complements of SEQ ID NOS 1-8 but not to a complement of the nucleotide sequence of said first oligonucleotide probe; and wherein said first oligonucleotide probe and said second oligonucleotide probes comprise nucleic acid molecules selected from the group consisting of SEQ ID NOS 1-8 and the complements of SEQ ID NOS 1-8
  • Claim: contacting said first and said second oligonucleotide probes to the test sample; and
  • Claim: analyzing binding of said first and said second oligonucleotide probes to the test sample.
  • Claim: 8. The method of claim 7 further comprising the step of
  • Claim: isolating nucleic acid from the test sample.
  • Claim: 9. The method of claim 8 further comprising the step of: amplifying the nucleic acid isolated from the test sample using polymerase chain reaction.
  • Claim: 10. The method of claim 9 wherein the amplifying step comprises the step of adding a first oligonucleotide primer and a second oligonucleotide primer to the nucleic acid isolated from the test sample, the first and second oligonucleotide primers together capable of selectively mediating amplification of a polynucleotide derived from a Citrus Tristeza Virus to which the oligonucleotide probe can hybridize.
  • Claim: 11. The method of claim 10 wherein the first oligonucleotide primer consists essentially of SEQ ID NO:10, and the second oligonucleotide primer consists essentially of SEQ ID NO:11.
  • Claim: 12. The method of claim 7, wherein said first oligonucleotide probe and said second oligonucleotide probe comprise nucleic acid molecules selected from the group consisting of: SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, and SEQ ID NO:8.
  • Claim: 13. A kit for identifying a strain of Citrus Tristeza Virus, the kit comprising
  • Claim: a first oligonucleotide primer and a second oligonucleotide primer, the first and second oligonucleotide primers together capable of selectively mediating amplification of a polynucleotide derived from Citrus Tristeza Virus; and
  • Claim: at least a first oligonucleotide probe and a second oligonucleotide probe, said first oligonucleotide probe hybridizing at 42 degrees Celsius in the presence of 6.times.SSC and 1% SDS to a nucleic acid molecule selected from the group consisting of SEQ ID NOS 1-8 and the complements of SEQ ID NOS 1-8, and said second oligonucleotide probe hybridizing at 42 degrees Celsius in the presence of 6.times.SSC and 1% SDS to a nucleic acid molecule selected from the group consisting of SEQ ID NOS 1-8 and the complements of SEQ ID NOS 1-8 but not to a complement of the nucleotide sequence of said first oligonucleotide probe; and wherein said first oligonucleotide probe and said second oligonucleotide probes comprise nucleic acid molecules selected from the group consisting of SEQ ID NOS 1-8 and the complements of SEQ ID NOS 1-8.
  • Claim: 14. The kit of claim 13 further comprising a control oligonucleotide probe wherein the control oligonucleotide probe is shared among substantially all strains of Citrus Tristeza Virus and is set forth in SEQ ID NO 9.
  • Claim: 15. An isolated nucleic acid molecule that hybridizes at 42 degrees Celsius in the presence of 6.times.SSC and 1% SDS to an oligonucleotide selected from the group consisting of: SEQ ID NOS 1-9 and the complements of SEQ ID NOS 1-9, wherein the isolated nucleic acid molecule is selected from the group consisting of: SEQ ID NOS 1-9 and the complements of SEQ ID NOS 1-9.
  • Claim: 16. The isolated nucleic acid molecule of claim 15, wherein the nucleic acid molecule is selected from the group consisting of: SEQ ID NOS:1-9.
  • Claim: 17. The isolated nucleic acid molecule of claim 16, wherein the nucleic acid molecule is SEQ ID NO:1.
  • Claim: 18. The isolated nucleic acid molecule of claim 16, wherein the nucleic acid molecule is SEQ ID NO:2.
  • Claim: 19. The isolated nucleic acid molecule of claim 16, wherein the nucleic acid molecule is SEQ ID NO:3.
  • Claim: 20. The isolated nucleic acid molecule of claim 16, wherein the nucleic acid molecule is SEQ ID NO:4.
  • Claim: 21. The isolated nucleic acid molecule of claim 16, wherein the nucleic acid molecule is SEQ ID NO:5.
  • Claim: 22. The isolated nucleic acid molecule of claim 16, wherein the nucleic acid molecule is SEQ ID NO:6.
  • Claim: 23. The isolated nucleic acid molecule of claim 16, wherein the nucleic acid molecule is SEQ ID NO:7.
  • Claim: 24. The isolated nucleic acid molecule of claim 16, wherein the nucleic acid molecule is SEQ ID NO:8.
  • Claim: 25. The isolated nucleic acid molecule of claim 16, wherein the nucleic acid molecule is SEQ ID NO:8.
  • Claim: 26. The isolated nucleic acid molecule of claim 16, wherein the nucleic acid molecule is SEQ ID NO:9.
  • Current U.S. Class: 435/6; 435/911; 536/234
  • Current International Class: C12Q 168; C12P 1934; C07H 2104
  • Patent References Cited: 5104789 April 1992 Permar et al. ; 5593836 January 1997 Niemiec et al.
  • Other References: Chassin et al., accession No. L34839, 1996. ; Pappu et al., accession No. L12175, 1993. ; Cepeda-Nieto et al., acession No. U32116, 1995. ; Gyapay et al., accession No. Z23729, 1996. ; Karasev et al. Virology, vol. 208, pp. 511-520, 1995. ; Mawassi et al. Virus Genes, vol. 7, pp. 265-275, 1993. ; Pappu et al. PNAS vol. 90, pp. 3641-3644, 1993. ; Pappu, H.R., et al., "Molecular characterization of a structural epitope that is largely conserved among severe isolates of a plant virus," Proc. Natl. Acad. Sci. USA, 90:3641-3644 (Apr. 1993). ; Pappu, H.R., et al., "Mutagenic Analysis and Localization of a Highly Conserved Epitope Near the Amino Terminal End of the Citrus Tristeza Closterovirus Capsid Protein," Phytopathology, 85(10):1311-1315 (1995). ; Permar, T.A., et al., "A Monoclonal Antibody That Discriminates Strains of Citrus Tristeza Cirus," Phytopathology, 80(9):224-228 (1990).
  • Primary Examiner: Jones, W. Gary
  • Assistant Examiner: Souaya, Jehanne
  • Attorney, Agent or Firm: Quarles & Brady LLP

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -